ホーム>>Signaling Pathways>> Neuroscience>> Pain Research>>1,2,3,4-Tetrahydro-β-carboline

1,2,3,4-Tetrahydro-β-carboline (Synonyms: Tetrahydronorharman, Tetrahydro-β-carboline, THBC, Tryptoline)

カタログ番号GC46366

セロトニン再取り込み阻害剤であり、トリプタミンの代謝物です。

Products are for research use only. Not for human use. We do not sell to patients.

1,2,3,4-Tetrahydro-β-carboline 化学構造

Cas No.: 16502-01-5

サイズ 価格 在庫数 個数
1 g
$34.00
在庫あり
5 g
$111.00
在庫あり

Tel:(909) 407-4943 Email: sales@glpbio.com

顧客レビュー

カスタマーレビューに基づきます。

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents

1,2,3,4-Tetrahydro-β-carboline is a serotonin reuptake inhibitor (IC50 = 7.4 µM in rat brain homogenates) and metabolite of tryptamine .1 In vivo, 1,2,3,4-tetrahydro-β-carboline (20 and 40 µg/animal, i.c.v.) reduces serotonin levels in rat forebrain. It induces serotonin-mediated hyperactivity syndrome (HHS) in rats (ED50 = 48 mg/kg).2 1,2,3,4-Tetrahydro-β-carboline (6.25-75 mg/kg) also reduces acetic acid-induced writhing in rats.3

1.Rommelspacher, H., Bade, P., Coper, H., et al.Inhibition of the reuptake of serotonin by tryptolineNaunyn Schmiedebergs Arch. Pharmacol.292(1)93-95(1976) 2.Pannier, L., and Rommelspacher, H.Actions of tetrahydronorharmane (tetrahydro-β-carboline) on 5-hydroxytryptamine and dopamine mediated mechanismsNeuropharmacology20(1)1-8(1981) 3.Rommelspacher, H., Kauffmann, H., Cohnitz, C.H., et al.Pharmacological properties of tetrahydronorharmane (tryptoline)Naunyn Schmiedebergs Arch. Pharmacol.298(2)83-91(1977)

レビュー

Review for 1,2,3,4-Tetrahydro-β-carboline

Average Rating: 5 ★★★★★ (Based on Reviews and 34 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for 1,2,3,4-Tetrahydro-β-carboline

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.